Drug Trial Radar · NCT02050724
ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT
Last checked: Nov 20, 2026Latest source record: Feb 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
11
Actual
Start
Nov 2013
Primary completion
Dec 31, 2016
Study completion Dec 31, 2016
Sponsor
- Lead sponsor
- Cantonal Hospital of St. GallenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 31, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- Single (investigator)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Title ThoHSpEkt Study Design Pilot Study concerning the technical operative methods and a phase II study concerning the radiopharmaceutical (therapeutic-explorative study with an approved drug in a new indication) Location Kantonsspital St.Gallen Aim Proof of feasibility of thoracoscopic ectomy of radioactively marked pulmonary nodules with the help of free-hand SPECT. Background In the Cantonal Hospital of St.Gallen an average of 30 - 40 patients will be operated with thoracoscopic ectomy for a pulmonary nodule. When localisation of the nodule is not possible a switch to minithoracotomy is performed. Study intervention Marking of pulmonary nodules with radioactivity. Free-hand SPECT guided surgery Risks Risks of bronchoscopic or CT-intervention Radiation risk (minimal) Rational for patient number 10 patients for each group are enough to prove the feasibility, to manage difficulties and to record complications Duration approximately 24 months.
Conditions
- Solitary Pulmonary Nodule
- Bronchial Neoplasms
Interventions
Radioactive labelling of pulmonary nodulesDrug
Application directly into a pulmonary nodule
CT guided radioactive labellingDevice
CT guided puncture is a standard procedure in radiology. In this study it is used to mark pulmonary nodules for the following thoracoscopic surgery, done with a handheld-SPECT device.
Electromagnetic guided bronchoscopic radioactive labellingDevice
Electromagnetic guided bronchoscopy is a standard procedure. In this study it is used to mark pulmonary nodules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful thoracoscopic ectomiesTime frame: 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cantonal Hospital St.Gallen
Sankt Gallen, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.